FILATENKOV ALEXANDER ET AL: "Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 15 AUG 2015, vol. 21, no. 16, 15 August 2015 (2015-08-15), pages 3727 - 3739, ISSN: 1078-0432 (B1)

H. LIANG ET AL.: "Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing.", THE JOURNAL OF IMMUNOLOGY, vol. 190, no. 11, 1 June 2013 (2013-06-01), USA, pages 5874 - 5881, XP002743473 (B1)

J. ZENG ET AL.: "Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.", INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 86, no. 2, 22 February 2013 (2013-02-22), USA, pages 343 - 349, XP028531184 (B1)

K. PILONES ET AL: "Abstract 5020: Cooperative effects of programmed cell death-1 blockade and radiation in a model of a poorly immunogenic breast carcinoma", PROCEEDINGS OF THE 105TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF CANCER RESEARCH, vol. 74, no. 19 Suppl, 1 October 2014 (2014-10-01), XP055659598 (B1)

WO-A2-2012/177624 (B1)

LEE YOUJIN ET AL: "Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.", BLOOD 16 JUL 2009, vol. 114, no. 3, 16 July 2009 (2009-07-16), pages 589 - 595, XP055978014, ISSN: 1528-0020, DOI: 10.1182/blood-2009-02-206870 (B1)

S. DOVEDI ET AL.: "Acquired resistance to fractionated radiotherapy can be overcome by cocurrent PD-L1 blockade.", CANCER RESEARCH, vol. 74, no. 19, 1 October 2014 (2014-10-01), USA, pages 5458 - 5468, XP002743474 (B1)

WO-A1-2013/079174 (B1)

WO-A1-2013/190555 (B1)

L. DENG ET AL.: "Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 124, no. 2, 3 February 2014 (2014-02-03), USA, pages 687 - 695, XP002743472 (B1)